Search Results 511-520 of 23340 for B cell lymphomas
... B-cell malignancies. ... Indolent / aggressive B-cell (NHL) Non- Hodgkin's Lymphoma: EXCLUDING: Burkitt lymphoma and precursor B-lymphoblastic leukemia/lymphoma.
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
... B lymphocytes (as defined by CD19+) which are monoclonal (by light chain exclusion); CLL will be diagnosed if these cells have ≥ 3 of the following ...
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas. Blood Cancer J. 2024 Oct 9; 14 (1):172 ...
Multiple myeloma, B-cell lymphoma, Non-Hodgkin lymphoma, T-cell lymphoma, Small lymphocytic lymphoma, Follicular lymphoma, Hodgkin lymphoma ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
Burkitt lymphoma · Cancer · Chronic granulomatous disease · Chronic lymphocytic leukemia · Chronic myelogenous leukemia · Diffuse large B-cell lymphoma ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study of CA-4948 in Patients With ...
B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480. Accessed Aug. 30, 2024. T ...
... B-Cell Lymphomas With Plasmacytic Differentiation? Am J Clin Pathol. 2018 Jul 3; 150 (2):168-176. View PubMed; Reinig EF, Greipp PT, Chiu A, Howard MT ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.